What's in a name? Dilemmas in nomenclature characterizing hypertrophic cardiomyopathy and left ventricular hypertrophy

Circulation: Cardiovascular Genetics

Volumn 2, Issue 1, 2009, Pages 81-85

  Maron, Barry J ^e   Seidman, Christine E ^a   Ackerman, Michael J ^b   Towbin, Jeffrey A ^c   Maron, Martin S ^d   Ommen, Steve R ^b   Nishimura, Rick A ^b   Gersh, Bernard J ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MAYO CLINIC   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d TUFTS MEDICAL CENTER   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; GENE MUTATION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; NOONAN SYNDROME; NOTE; PRIORITY JOURNAL; ARTICLE; CLASSIFICATION; GENETICS; NOMENCLATURE; PREVALENCE;

CARDIOMYOPATHY, HYPERTROPHIC; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; PREVALENCE; TERMINOLOGY AS TOPIC;

EID: 77449148896     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.108.788703     Document Type: Note

References (23)

1. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH, Spirito P, ten Cate FJ, Wigle ED. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines Committee to Develop an Expert Consensus Document on Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 2003; 42: 1687-1713. (Pubitemid 37383745)
2. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA. 2002; 287: 1308-1320.
3. Seidman JG, Seidman C. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell. 2001; 104: 557-567.
4. Ahmad F, Seidman JG, Seidman CE. The genetic basis for cardiac remodeling. Annu Rev Genomics Hum Genet. 2005; 6: 185-216.
5. Bos JM, Ommen SR, Ackerman MJ. Genetics of hypertrophic cardiomyopathy: one, two, or more diseases? Curr Opin Cardiol. 2007; 22: 193-199.
6. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB. Contemporary definitions and classification of the cardiomyopathies. An American Heart Association Scientific Statement from the Council of Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006; 113: 1807-1816.
7. Maron BJ, Epstein SE. Hypertrophic cardiomyopathy: a discussion of nomenclature. Am J Cardiol. 1979; 43: 1242-1244.
8. Maron BJ, Gardin JM, Flack JM, Gidding SS, Bild D. Assessment of the prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA Study. Circulation. 1995; 92: 785-789.
9. Maron BJ. Hypertrophic cardiomyopathy: an important global disease [Editorial]. Am J Med. 2004; 116: 63-65.
10. Maron MS, Olivotto I, Zenovich AG, Link MS, Pandian NG, Kuvin JT, Nistri S, Cecchi F, Udelson JE, Maron BJ. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation. 2006; 114: 2232-2239. (Pubitemid 44789498)
11. Pandit B, Sarkozy A, Pennacchio LA, Carta C, Oishi K, Martinelli S, Pogna EA, Schackwitz W, Ustaszewska A, Landstrom A, Bos JM, Ommen SR, Esposistio G, Lepri F, Faul C, Mundel P, Siguero J P L, Tenconi R, Selicorni A, Rossi C, Mazzanti L, Torrente I, Marino B, Digilio MC, Zampino G, Ackerman MJ, Dallapiccola B, Tartaglia M, Gelb BD. Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy. Nat Genet. 2007; 39: 1007-1012.
12. Yang Z, McMahon CJ, Smith LR, Bersola J, Adesina AM, Kearney DL, Dreyer WJ, Denfield SW, Price JF, Grenier M, Kertesz NJ, Clunie S, Fernbach SD, Southern JF, Berger S, Towbin JA, Bowles KR, Bowles NE. Danon disease as a frequent cause of hypertrophic cardiomyopathy in children. Circulation. 2005; 112: 1612-1617.
13. Arad M, Maron BJ, Gorham JM, Johnson WH, Saul JP, Perez-Atayde AR, Spirito P, Wright GB, Kanter RJ, Seidman CE, Seidman JG. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med. 2005; 352: 362-372.
14. Monserrat L, Gimeno-Blanes JR, Marín F, Hermida-Prieto M, Garcia-Honrubia A, Pérez-Fernández X, de Nicolas R, de la Morena G, Payá E, Yagüe J, Egido J. Prevalence of Fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2007; 50: 2399-2403.
15. Topol EJ, Traill TA, Fortuin NJ. Hypertensive hypertrophic cardiomyopathy in the elderly. N Engl J Med. 1985; 312: 277-283.
16. Ackerman MJ, Van Driest SL, Ommen SR, ill ML, Nishimura RA, Tajik AJ, Gersh BJ. Prevalence and age dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective. J Am Coll Cardiol. 2002; 39: 2042-2048.
17. Van Driest SL, Ackerman MJ, Ommen SR, Shakur R, Will ML, Nishimura RA, Tajik AJ, Gersh BJ. Prevalence and severity of "benign" mutations in the beta-myosin heavy chain, cardiac troponin T, and alphatropomyosin genes in hypertrophic cardiomyopathy. Circulation. 2002; 106: 3085-3090.
18. Bowles NE, Bowles KR, Towbin JA. The "final common pathway" hypothesis and inherited cardiovascular disease. The role of cytoskeletal proteins in dilated cardiomyopathy. Herz. 2000; 25: 168-175.
19. Landstrom A, Batalden KB, Weisleder N, Box JM, Tester DJ, Ommen SR, Wehrens X H T, Claybomb WC, Ko J, Hwang M, Pan Z, Ma J, Ackerman NJ. Mutation sin JPH2-encoded junctophilin-2 associated with hypertrophic cardiomyopathy in humans. J Mol Cell Cardiol. 2007; 42: 1026-1035.
20. Theis JL, Bos JM, Bartleson VB, Will ML, Binder J, Vatta M, Towbin JA, Gersh BJ, Ommen SR, Ackerman MJ. Echocardiographic-determined septal morphology in z-disc hypertrophic cardiomyopathy. Biochem Biophys Res Commun. 2006; 351: 896-902.
21. Morita H, Rehm HL, Menesses A, McDonough B, Roberts AE, Kucherlapati R, Towbin JA, Seidman JG, Seidman CE. Shared genetic causes of cardiac hypertrophy in children and adults. N Engl J Med. 2008; 358: 18: 1899-1908.
22. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kühl U, Maisch B, McKenna WJ, Monserrat L, Pankuweit S, Rapezzi C, Seferovic P, Tavazzi L, Keren A. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart. 2008; 29: 270-276.
23. Colan SD, Lipshultz SE, Lowe AM, Sleeper LA, Messere J, Cox GF, Lurie PR, Orav EJ, Towbin JA. Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children. Findings from the Pediatric Cardiomyopathy Registry. Circulation. 2007; 115: 773-781.